Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases

We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.

Detalles Bibliográficos
Autores principales: Hartley, James Leon, Bailey, Neil, Sharma, Asheesh, Shawki, Howida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900021/
https://www.ncbi.nlm.nih.gov/pubmed/35246429
http://dx.doi.org/10.1136/bcr-2021-244638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900021/
https://www.ncbi.nlm.nih.gov/pubmed/35246429
http://dx.doi.org/10.1136/bcr-2021-244638

Ejemplares similares